BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Financial Ratios
Natco Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524816
ISIN Demat
INE987B01026
Book Value (Rs)
461.79599
NSE Symbol
NATCOPHARM
Divident Yield %
0.72
Market Cap
(Rs In Cr.)
14,937
P/E (TTM)
9.84
EPS (TTM)
84.75
Face Value
(Rs)
2
ParticularsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.050.050.060.080.07
Long Term Debt-Equity Ratio0.000.000.000.000.00
Current Ratio3.703.212.973.053.38
Fixed Assets1.151.100.770.630.69
Inventory6.615.883.582.412.56
Debtors3.633.823.443.623.53
Interest Cover Ratio114.57108.2690.629.5135.71
PBIDTM (%)60.2248.8039.5714.9831.37
PBITM (%)54.8443.9933.157.1624.40
PBDTM (%)59.7448.4039.2014.2330.69
CPM (%)50.5741.4333.5213.7925.68
APATM (%)45.1936.6127.105.9618.72
ROCE (%)32.7528.5816.172.779.25
RONW (%)28.6325.3814.332.547.78
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)